101 related articles for article (PubMed ID: 38718754)
1. Dysregulated BH4 metabolism facilitates immunosuppression in pancreatic cancer.
Cronin SJF
Cell Metab; 2024 May; 36(5):886-888. PubMed ID: 38718754
[TBL] [Abstract][Full Text] [Related]
2. QDPR deficiency drives immune suppression in pancreatic cancer.
Liu J; He X; Deng S; Zhao S; Zhang S; Chen Z; Xue C; Zeng L; Zhao H; Zhou Y; Bai R; Xu Z; Liu S; Zhou Q; Li M; Zhang J; Huang X; Chen R; Wang L; Lin D; Zheng J
Cell Metab; 2024 May; 36(5):984-999.e8. PubMed ID: 38642552
[TBL] [Abstract][Full Text] [Related]
3. CD200 promotes immunosuppression in the pancreatic tumor microenvironment.
Choueiry F; Torok M; Shakya R; Agrawal K; Deems A; Benner B; Hinton A; Shaffer J; Blaser BW; Noonan AM; Williams TM; Dillhoff M; Conwell DL; Hart PA; Cruz-Monserrate Z; Bai XF; Carson WE; Mace TA
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581043
[TBL] [Abstract][Full Text] [Related]
4. Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.
Jiang H; Hegde S; Knolhoff BL; Zhu Y; Herndon JM; Meyer MA; Nywening TM; Hawkins WG; Shapiro IM; Weaver DT; Pachter JA; Wang-Gillam A; DeNardo DG
Nat Med; 2016 Aug; 22(8):851-60. PubMed ID: 27376576
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer immune evasion mechanisms: the immunosuppressive role of P2RX1-negative neutrophils.
Audrito V
Purinergic Signal; 2021 Jun; 17(2):173-174. PubMed ID: 33786722
[No Abstract] [Full Text] [Related]
6. Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression.
Kaneda MM; Cappello P; Nguyen AV; Ralainirina N; Hardamon CR; Foubert P; Schmid MC; Sun P; Mose E; Bouvet M; Lowy AM; Valasek MA; Sasik R; Novelli F; Hirsch E; Varner JA
Cancer Discov; 2016 Aug; 6(8):870-85. PubMed ID: 27179037
[TBL] [Abstract][Full Text] [Related]
7. Complex role for the immune system in initiation and progression of pancreatic cancer.
Inman KS; Francis AA; Murray NR
World J Gastroenterol; 2014 Aug; 20(32):11160-81. PubMed ID: 25170202
[TBL] [Abstract][Full Text] [Related]
8. Obesity-Induced Adipose Tissue Inflammation as a Strong Promotional Factor for Pancreatic Ductal Adenocarcinoma.
Chang HH; Eibl G
Cells; 2019 Jul; 8(7):. PubMed ID: 31277269
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic Stellate Cells Promote Tumor Progression by Promoting an Immunosuppressive Microenvironment in Murine Models of Pancreatic Cancer.
Li C; Cui L; Yang L; Wang B; Zhuo Y; Zhang L; Wang X; Zhang Q; Zhang S
Pancreas; 2020 Jan; 49(1):120-127. PubMed ID: 31856087
[TBL] [Abstract][Full Text] [Related]
10. Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma.
Murakami S; Shahbazian D; Surana R; Zhang W; Chen H; Graham GT; White SM; Weiner LM; Yi C
Oncogene; 2017 Mar; 36(9):1232-1244. PubMed ID: 27546622
[TBL] [Abstract][Full Text] [Related]
11. Metabolome of Pancreatic Juice Delineates Distinct Clinical Profiles of Pancreatic Cancer and Reveals a Link between Glucose Metabolism and PD-1
Cortese N; Capretti G; Barbagallo M; Rigamonti A; Takis PG; Castino GF; Vignali D; Maggi G; Gavazzi F; Ridolfi C; Nappo G; Donisi G; Erreni M; Avigni R; Rahal D; Spaggiari P; Roncalli M; Cappello P; Novelli F; Monti P; Zerbi A; Allavena P; Mantovani A; Marchesi F
Cancer Immunol Res; 2020 Apr; 8(4):493-505. PubMed ID: 32019781
[TBL] [Abstract][Full Text] [Related]
12. CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer.
Faraoni EY; Singh K; Chandra V; Le Roux O; Dai Y; Sahin I; O'Brien BJ; Strickland LN; Li L; Vucic E; Warner AN; Pruski M; Clark T; Van Buren G; Thosani NC; Bynon JS; Wray CJ; Bar-Sagi D; Poulsen KL; Vornik LA; Savage MI; Sei S; Mohammed A; Zhao Z; Brown PH; Mills T; Eltzschig HK; McAllister F; Bailey-Lundberg JM
Cancer Res; 2023 Apr; 83(7):1111-1127. PubMed ID: 36720042
[TBL] [Abstract][Full Text] [Related]
13. IFNα-induced BST2
Zheng C; Wang J; Zhou Y; Duan Y; Zheng R; Xie Y; Wei X; Wu J; Shen H; Ye M; Kong B; Liu Y; Xu P; Zhang Q; Liang T
Cell Rep; 2024 Apr; 43(4):114088. PubMed ID: 38602878
[TBL] [Abstract][Full Text] [Related]
14. Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy.
Zhang YF; Jiang SH; Hu LP; Huang PQ; Wang X; Li J; Zhang XL; Nie HZ; Zhang ZG
Chin Clin Oncol; 2019 Apr; 8(2):18. PubMed ID: 31070038
[TBL] [Abstract][Full Text] [Related]
15. An Immunological Glance on Pancreatic Ductal Adenocarcinoma.
Melzer MK; Arnold F; Stifter K; Zengerling F; Azoitei N; Seufferlein T; Bolenz C; Kleger A
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397303
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment.
Foucher ED; Ghigo C; Chouaib S; Galon J; Iovanna J; Olive D
Front Immunol; 2018; 9():1044. PubMed ID: 29868007
[TBL] [Abstract][Full Text] [Related]
17. Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy.
Koikawa K; Kibe S; Suizu F; Sekino N; Kim N; Manz TD; Pinch BJ; Akshinthala D; Verma A; Gaglia G; Nezu Y; Ke S; Qiu C; Ohuchida K; Oda Y; Lee TH; Wegiel B; Clohessy JG; London N; Santagata S; Wulf GM; Hidalgo M; Muthuswamy SK; Nakamura M; Gray NS; Zhou XZ; Lu KP
Cell; 2021 Sep; 184(18):4753-4771.e27. PubMed ID: 34388391
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapeutic strategies in pancreatic ductal adenocarcinoma (PDAC): current perspectives and future prospects.
Nsingwane Z; Candy G; Devar J; Omoshoro-Jones J; Smith M; Nweke E
Mol Biol Rep; 2020 Aug; 47(8):6269-6280. PubMed ID: 32661873
[TBL] [Abstract][Full Text] [Related]
19. Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor's arsenal.
Mundry CS; Eberle KC; Singh PK; Hollingsworth MA; Mehla K
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188387. PubMed ID: 32579889
[TBL] [Abstract][Full Text] [Related]
20. Modeling pancreatic cancer in mice for experimental therapeutics.
Mallya K; Gautam SK; Aithal A; Batra SK; Jain M
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188554. PubMed ID: 33945847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
